Cover Image
市場調查報告書

美國質子射線治療市場預測:不同類型癌症(共14種)的患者數、醫療費用報銷政策、在各中心治療中的患者數

United States Proton Therapy Market, Patients by 14 Cancer Types, Reimbursement Policy & Persons Treated at Centers

出版商 Renub Research 商品編碼 484586
出版日期 內容資訊 英文 147 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
美國質子射線治療市場預測:不同類型癌症(共14種)的患者數、醫療費用報銷政策、在各中心治療中的患者數 United States Proton Therapy Market, Patients by 14 Cancer Types, Reimbursement Policy & Persons Treated at Centers
出版日期: 2018年03月27日 內容資訊: 英文 147 Pages
簡介

美國國內質子射線治療市場估計在2024年達到160億美元。美國一個國家就佔了全球質子射線治療市場40%以上。目前,有14所質子射線治療中心正在建設或計畫,預計市場規模和患者數量將進一步擴大。

本報告中針對美國質子射線治療市場進行調查分析,提供市場規模預測、患者數量變化、不同癌症及不同治療中心的詳細動態、正在運作、建設或計畫中的治療中心資訊、醫療費用報銷制度、促進成長要素及課題等系統性資訊。

第1章 執行摘要

第2章 美國質子射線治療市場:實際價值和預測值 (總共16年分)

  • 質子射線治療的實際市場規模
  • 質子射線治療的潛在市場規模

第3章 患者數量:美國質子射線治療市場 (總共16年分)

  • 實際患者數量
  • 潛在患者數量

第4章 癌症種類:美國國內質子射線治療患者數量 (總共16年分)

  • 中樞神經系統腫瘤
  • 眼球黑色素瘤
  • 下垂體瘤
  • 顱底和軸骨腫瘤
  • 頭頸癌
  • 肺癌
  • 腹膜後肉瘤
  • 小兒癌症 (18歲前發病病例)
  • 消化器官癌
  • 泌尿道腫瘤
  • 婦女病、骨盆內器官癌症
  • 前列腺癌
  • 乳癌
  • 所有其他癌症

第5章 癌症種類:美國國內質子射線治療市場規模(總共16年分)

  • 中樞神經系統腫瘤
  • 眼球黑色素瘤
  • 下垂體瘤
  • 顱底和軸骨腫瘤
  • 頭頸癌
  • 肺癌
  • 腹膜後肉瘤
  • 小兒癌症 (18歲前發病病例)
  • 消化器官癌
  • 泌尿道腫瘤
  • 婦女病、骨盆內器官癌症
  • 前列腺癌
  • 乳癌
  • 所有其他癌症

第6章 美國國內質子射線治療中心一覽

  • 目前正在運行的質子射線治療中心
  • 目前正在建設的質子射線治療中心
  • 目前正在計畫的質子射線治療中心

第7章 質子射線治療患者數量動態:依不同中心分類

  • Loma Linda (LLUMC) Proton Therapy Center
  • UCSF - CNL Proton Therapy Center
  • Boston (NPTC) Proton Therapy Center
  • Bloomington (MPRI, 2) Proton Therapy Center
  • Houston (MD Anderson) Proton Therapy Center
  • UFPTI Jacksonville Proton Therapy Center
  • Oklahoma City (ProCure PTC) Proton Therapy Center
  • CDH Warrenville Proton Therapy Center
  • Philadelphia (Upenn) Proton Therapy Center
  • Hampton (HUPTI) Proton Therapy Center
  • New Jersey (ProCure PTC) Proton Therapy Center
  • Seattle (SCCA ProCure PTC) Proton Therapy Center
  • St. Louis (S. Lee King PTC) Proton Therapy Center
  • Provision Center for Proton Therapy, Knoxville, TN
  • San Diego (Scripps PTC) (2014 - 2017)
  • Shreveport (Willis Knighton) Proton Therapy Center
  • Jacksonville (Ackerman CC) Proton Therapy Center
  • Rochester (Mayo PBTC) Proton Therapy Center
  • Brunswick (Laurie PC) Proton Therapy Center
  • Irving (Texas Center for PT) Proton Therapy Center
  • Memphis (St. Jude PTC) Proton Therapy Center
  • Phoenix (Mayo PBTC) Proton Therapy Center
  • Baltimore (Maryland PTC) Proton Therapy Center
  • Cincinnati (Children's PTC) Proton Therapy Center
  • Orlando (Orlando Health PTC) Proton Therapy Center
  • Cleveland (UH Sideman PTC) Proton Therapy Center

第8章 質子射線治療:醫療費用報銷政策

  • 質子射線治療醫療費用報銷政策:患者用
  • 質子射線治療醫療費用報銷政策:醫療機構、利害關係人、廠商用

第9章 標準質子射線治療中心構成要件

  • 質子加速器
    • 同步加速器
    • 迴旋加速器
    • 同步迴旋加速器
    • 直線加速器
    • 氫負極離子同步加速器
    • 分離磁區迴旋加速器
    • 超傳導迴旋加速器
    • 高速旋轉同步加速器
  • 光束傳輸系統
  • 光束供應系統
    • 被動散射法
    • 光束掃瞄
  • 噴嘴
    • 單散射
    • 雙散射
    • 均勻散射噴嘴
    • 散射鉛筆噴嘴
  • 治療計畫系統
  • 圖像檢視器
  • 患者定位系統 (PPS)
  • 人力資源

第10章 企業分析 (總共12年分)

  • IBA Proton Therapy
    • 銷售額分析
  • Varian Medical Systems
  • Elekta

第11章 質子射線治療促進要素

第12章 質子射線治療的課題

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

United States proton therapy market has potential to surpass US$ 16 Billion by the end of 2024. In current outlook United States captures more than 40 percent of Proton Beam Therapy Facility worldwide. The growth of proton therapy center in United States is substantial and the number of new advanced proton therapy center would be launched in forecast time-frame. In United States, almost 14 centers are in development phase (either under-construction or planning phase) will further boost the market of proton therapy.

By 14 Cancer Types - United States Proton Therapy Market & Patients

In this report, we have done comprehensive analysis of proton therapy market and proton therapy patient numbers by 14 cancer/tumor types to understand which cancer type has more or less inclination towards proton therapy technology. In proton therapy, the frequency of patients is much higher in prostate cancer followed by pediatric cancer because of its compatibility and survival rate. The report covers 14 cancer types as follows: Central Nervous System Tumors, Lung Cancer, Pituitary Neoplasms Cancer, Pediatric Cancer Cases (Up to Age 18), Base of Skull / Axial Skeleton Cancer, Urinary Tract Cancer, Head and Neck Cancer, Gastrointestinal Tract Cancer, Intraocular Melanomas Cancer, Retroperitoneal Sarcoma Cancer, Breast Cancer, Female Pelvic Organs Cancer, Prostate Cancer & Other Cancer.

Annually Treated Patient Database by Proton Therapy Center in United States

In this report, we have covered the number of proton therapy patients treated by each proton therapy center since their inception and till 2017 on annual basis. According to Renub Research findings, proton therapy center in United States efficiently manage the patients. Moreover they are also expanding their capacity, improving technical skills and changing minor technology for the treatment of more people simultaneously.

United States Reimbursement Policy regarding Proton Beam Therapy

In this report, we have done complete assessment on United States proton therapy reimbursement policies. We have divided the reimbursement policy into two sections; by patients and by manufacturer, stakeholder and institutions.

United States Proton Therapy Market, Patients by 14 Cancer Types (Central Nervous System Tumors, Intraocular Melanomas Cancer, Pituitary Neoplasms Cancer, Base of Skull / Axial Skeleton Cancer, Head and Neck Cancer, Lung Cancer, Retroperitoneal Sarcoma Cancer, Pediatric Cancer Cases (Up to Age 18), Gastrointestinal Tract Cancer, Urinary Tract Cancer, Female Pelvic Organs Cancer, Prostate Cancer, Breast Cancer & Other Cancer) Reimbursement Policies & Persons Treated at Centers is a report published by Renub Research. In this report we have studied the market in two parts a) Actual Market and b) Potential Market. The report also talks about list of all operational and future Proton Therapy centers; Economics of proton therapy including reimbursement policies. Proton Therapy revenues from 3 companies (IBA, Varian Medical Systems, Elekta) has also been studied in the report.

a) Actual Market is the current market which is already present

b) Potential Market is the market which can be achieved; but it has yet not been achieved due to demand and supply gap. At present only a few proton therapy centers are available that can treat a limited number of patients each year.

image1

United States Proton Therapy Market has been analyzed from 6 View Points (2009 - 2024)

  • Actual Market & Forecast
  • Potential Market & Forecast
  • By 14 Cancer Types - USA Proton Therapy Market
  • Patient Numbers & Forecast
  • Potential Patient Numbers & Forecast
  • By 14 Cancer Types - USA Proton Therapy Patient Numbers

Cancer Types - Proton Therapy Market & Patient Numbers

  • 1. Central Nervous System Tumors
  • 2. Intraocular Melanomas Cancer
  • 3. Pituitary Neoplasms Cancer
  • 4. Base of Skull / Axial Skeleton Cancer
  • 5. Head and Neck Cancer
  • 6. Lung Cancer
  • 7. Retroperitoneal Sarcoma Cancer
  • 8. Pediatric Cancer Cases (Up to Age 18)
  • 9. Gastrointestinal Tract Cancer
  • 10. Urinary Tract Cancer
  • 11. By Female Pelvic Organs Cancer
  • 12. Prostate Cancer
  • 13. Breast Cancer
  • 14. Other Cancer

Key Companies Covered

  • 1. IBA (Overview, Sales Analysis)
  • 2. Varian Medical Systems (Overview, Sales Analysis)
  • 3. Elekta (Overview, Sales Analysis)

Table of Contents

1. Executive Summary

2. Market (Actual & Potential) - United States Proton Therapy Market (2009 - 2024)

  • 2.1 Actual Proton Therapy Market
  • 2.2 Potential Proton Therapy Market

3. Number of Patients - United States Proton Therapy (2009 - 2024)

  • 3.1 Actual Numbers
  • 3.2 Potential Numbers

4. Cancer Types - Patients Number in United States Proton Therapy (2009 - 2024)

  • 4.1 Central Nervous System Tumors
  • 4.2 Intraocular Melanomas Cancer
  • 4.3 Pituitary Neoplasms Cancer
  • 4.4 Base of Skull / Axial Skeleton Cancer
  • 4.5 Head and Neck Cancer
  • 4.6 Lung Cancer
  • 4.7 Retroperitoneal Sarcoma Cancer
  • 4.8 Pediatric Cancer Cases (Up to Age 18)
  • 4.9 Gastrointestinal Tract Cancer
  • 4.10 Urinary Tract Cancer
  • 4.11 By Female Pelvic Organs Cancer
  • 4.12 Prostate Cancer
  • 4.13 Breast Cancer
  • 4.14 Other Cancer

5. Cancer Types - United States Proton Therapy Market (2009 - 2024)

  • 5.1 Central Nervous System Tumors
  • 5.2 Intraocular Melanomas Cancer
  • 5.3 Pituitary Neoplasms Cancer
  • 5.4 Base of Skull / Axial Skeleton Cancer
  • 5.5 Head and Neck Cancer
  • 5.6 Lung Cancer
  • 5.7 Retroperitoneal Sarcoma Cancer
  • 5.8 Pediatric Cancer (Up to Age 18)
  • 5.9 Gastrointestinal Tract Cancer
  • 5.10 Urinary Tract Cancer
  • 5.11 Female Pelvic Organs Cancer
  • 5.12 Prostate Cancer
  • 5.13 Breast Cancer
  • 5.14 Other Cancer

6. United States - List of Proton Therapy Centers

  • 6.1 Operating Proton Therapy Centers
  • 6.2 Under-Construction Therapy Centers
  • 6.3 Planning Proton Therapy Centers

7. By Centers - Number of Proton Therapy Patients Treated

  • 7.1 Loma Linda (LLUMC) Proton Therapy Center (2008 - 2016)
  • 7.2 UCSF - CNL Proton Therapy Center (2008 - 2015)
  • 7.3 Boston (NPTC) Proton Therapy Center (2008 - 2016)
  • 7.4 Bloomington (MPRI, 2) Proton Therapy Center (2008 - 2014)
  • 7.5 Houston (MD Anderson) Proton Therapy Center (2008 - 2016)
  • 7.6 UFPTI Jacksonville Proton Therapy Center (2008 - 2016)
  • 7.7 Oklahoma City (ProCure PTC) Proton Therapy Center (2009 - 2017)
  • 7.8 CDH Warrenville Proton Therapy Center (2010 - 2016)
  • 7.9 Philadelphia (Upenn) Proton Therapy Center (2011 - 2016)
  • 7.10 Hampton (HUPTI) Proton Therapy Center (2012 - 2016)
  • 7.11 New Jersey (ProCure PTC) Proton Therapy Center (2012 - 2016)
  • 7.12 Seattle (SCCA ProCure PTC) Proton Therapy Center (2013 - 2016)
  • 7.13 St. Louis (S. Lee King PTC) Proton Therapy Center (2013 - 2016)
  • 7.14 Provision Center for Proton Therapy, Knoxville, TN (2014 - 2016)
  • 7.15 San Diego (Scripps PTC) (2014 - 2017)
  • 7.16 Shreveport (Willis Knighton) Proton Therapy Center (2014 - 2017)
  • 7.17 Jacksonville (Ackerman CC) Proton Therapy Center (2015 - 2016)
  • 7.18 Rochester (Mayo PBTC) Proton Therapy Center (2015 - 2016)
  • 7.19 Brunswick (Laurie PC) Proton Therapy Center (2015)
  • 7.20 Irving (Texas Center for PT) Proton Therapy Center (2015 - 2017)
  • 7.21 Memphis (St. Jude PTC) Proton Therapy Center (2015 - 2017)
  • 7.22 Phoenix (Mayo PBTC) Proton Therapy Center (2016)
  • 7.23 Baltimore (Maryland PTC) Proton Therapy Center (2016)
  • 7.24 Cincinnati (Children's PTC) Proton Therapy Center (2016)
  • 7.25 Orlando (Orlando Health PTC) Proton Therapy Center (2016)
  • 7.26 Cleveland (UH Sideman PTC) Proton Therapy Center (2016)

8. Proton Therapy - Reimbursement Policies

  • 8.1 Proton Therapy Reimbursement Policies for Patients
  • 8.2 Proton Therapy Reimbursement for Institutions, Stakeholders and Manufacturers

9. Components of a Standard Proton Therapy Center

  • 9.1 Proton Accelerator
    • 9.1.1 Synchrotrons (example: LLUMC at Loma Linda)
    • 9.1.2 Cyclotrons (example: MGH Boston)
    • 9.1.3 Synchrocyclotrons (examples: Orsay, Uppsala)
    • 9.1.4 Linacs (Rome)
    • 9.1.5 H-minus Synchrotrons
    • 9.1.6 Separated Sector Cyclotrons
    • 9.1.7 Super-conducting Cyclotrons
    • 9.1.8 Fast Cycling Synchrotron
  • 9.2 Beam Transport System
  • 9.3 Beam Delivery System
    • 9.3.1 The Passive Scattering Technique
    • 9.3.2 Beam Scanning
  • 9.4 Nozzle
    • 9.4.1 Single Scattering
    • 9.4.2 Double Scattering
    • 9.4.3 Uniform Scanning Nozzle
    • 9.4.4 Pencil Scanning Nozzle
  • 9.5 Treatment Planning System
  • 9.6 Image Viewers
  • 9.7 Patient Positioning System (PPS)
  • 9.8 Human Resource

10. Company Analysis (2010 - 2021)

  • 10.1 IBA Proton Therapy
    • 10.1.1 Sales Analysis
  • 10.2 Varian Medical Systems
    • 10.2.1 Sales Analysis
  • 10.3 Elekta
    • 10.3.1 Sales Analysis

11. Driving Factors for Proton Therapy (Due to data confidentiality, driving factors have not been disclosed in this table of contents)

  • 11.1 Point No. 1
  • 11.2 Point No. 2

12. Challenges in Proton Therapy (Due to data confidentiality, challenges have not been disclosed in this table of contents)

  • 12.1 Point no. 1
  • 12.2 Point No. 2

List of Figures:

  • Figure 2 1: United States - Proton Therapy Market (Million US$), 2009 - 2017
  • Figure 2 2: United States - Forecast for Proton Therapy Market (Million US$), 2018 - 2024
  • Figure 2 3: United States - Potential Proton Therapy Market (Million US$), 2009 - 2017
  • Figure 2 4: United States - Forecast for Potential Proton Therapy Market (Million US$), 2018 - 2024
  • Figure 3 1: United States - Patient Treated with Proton Therapy (Number), 2009 - 2017
  • Figure 3 2: United States - Forecast for Patient Treated with Proton Therapy (Number), 2018 - 2024
  • Figure 3 3: United States - Potential Candidate for Proton Therapy (Number), 2009 - 2017
  • Figure 3 4: United States - Forecast for Potential Candidate for Proton Therapy (Number), 2018 - 2024
  • Figure 4 1: United States - Proton Therapy Patient by Central Nervous System Tumors (Number), 2009 - 2017
  • Figure 4 2: United States - Forecast for Proton Therapy Patient by Central Nervous System Tumors (Number), 2018 - 2024
  • Figure 4 3: United States - Proton Therapy Patient by Intraocular Melanomas Cancer (Number), 2009 - 2017
  • Figure 4 4: United States - Forecast for Proton Therapy Patient by Intraocular Melanomas Cancer (Number), 2018 - 2024
  • Figure 4 5: United States - Proton Therapy Patient by Pituitary Neoplasms Cancer (Number), 2009 - 2017
  • Figure 4 6: United States - Forecast for Proton Therapy Patient by Pituitary Neoplasms Cancer (Number), 2018 - 2024
  • Figure 4 7: United States - Proton Therapy Patient by Base of Skull / Axial Skeleton Cancer (Number), 2009 - 2017
  • Figure 4 8: United States - Forecast for Proton Therapy Patient by Base of Skull / Axial Skeleton Cancer (Number), 2018 - 2024
  • Figure 4 9: United States - Proton Therapy Patient by Head and Neck Cancer (Number), 2009 - 2017
  • Figure 4 10: United States - Forecast for Proton Therapy Patient by Head and Neck Cancer (Number), 2018 - 2024
  • Figure 4 11: United States - Proton Therapy Patient by Lung Cancer (Number), 2009 - 2017
  • Figure 4 12: United States - Forecast for Proton Therapy Patient by Lung Cancer (Number), 2018 - 2024
  • Figure 4 13: United States - Proton Therapy Patient by Retroperitoneal Sarcoma Cancer (Number), 2009 - 2017
  • Figure 4 14: United States - Forecast for Proton Therapy Patient by Retroperitoneal Sarcoma Cancer (Number), 2018 - 2024
  • Figure 4 15: United States - Proton Therapy Patient by Pediatric Cancer (Number), 2009 - 2017
  • Figure 4 16: United States - Forecast for Proton Therapy Patient by Pediatric Cancer (Number), 2018 - 2024
  • Figure 4 17: United States - Proton Therapy Patient by Gastrointestinal Tract Cancer (Number), 2009 - 2017
  • Figure 4 18: United States - Forecast for Proton Therapy Patient by Gastrointestinal Tract Cancer (Number), 2018 - 2024
  • Figure 4 19: United States - Proton Therapy Patient by Urinary Tract Cancer (Number), 2009 - 2017
  • Figure 4 20: United States - Forecast for Proton Therapy Patient by Urinary Tract Cancer (Number), 2018 - 2024
  • Figure 4 21: United States - Proton Therapy Patient by Female Pelvic Organs Cancer (Number), 2009 - 2017
  • Figure 4 22: United States - Forecast for Proton Therapy Patient by Female Pelvic Organs Cancer (Number), 2018 - 2024
  • Figure 4 23: United States - Proton Therapy Patient by Prostate Cancer (Number), 2009 - 2017
  • Figure 4 24: United States - Forecast for Proton Therapy Patient by Prostate Cancer (Number), 2018 - 2024
  • Figure 4 25: United States - Proton Therapy Patient by Breast Cancer (Number), 2009 - 2017
  • Figure 4 26: United States - Forecast for Proton Therapy Patient by Breast Cancer (Number), 2018 - 2024
  • Figure 4 27: United States - Proton Therapy Patient by Other Cancer (Number), 2009 - 2017
  • Figure 4 28: United States - Forecast for Proton Therapy Patient by Other Cancer (Number), 2018 - 2024
  • Figure 5 1: United States - Proton Therapy Market by Central Nervous System Tumors (Million US$), 2009 - 2017
  • Figure 5 2: United States - Forecast for Proton Therapy Market by Central Nervous System Tumors (Million US$), 2018 - 2024
  • Figure 5 3: United States - Proton Therapy Market by Intraocular Melanomas Cancer (Million US$), 2009 - 2017
  • Figure 5 4: United States - Forecast for Proton Therapy Market by Intraocular Melanomas Cancer (Million US$), 2018 - 2024
  • Figure 5 5: United States - Proton Therapy Market by Pituitary Neoplasms Cancer (Million US$), 2009 - 2017
  • Figure 5 6: United States - Forecast for Proton Therapy Market by Pituitary Neoplasms Cancer (Million US$), 2018 - 2024
  • Figure 5 7: United States - Proton Therapy Market by Base of Skull / Axial Skeleton Cancer (Million US$), 2009 - 2017
  • Figure 5 8: United States - Forecast for Proton Therapy Market by Base of Skull / Axial Skeleton Cancer (Million US$), 2018 - 2024
  • Figure 5 9: United States - Proton Therapy Market by Head and Neck Cancer (Million US$), 2009 - 2017
  • Figure 5 10: United States - Forecast for Proton Therapy Market by Head and Neck Cancer (Million US$), 2018 - 2024
  • Figure 5 11: United States - Proton Therapy Market by Lung Cancer (Million US$), 2009 - 2017
  • Figure 5 12: United States - Forecast for Proton Therapy Market by Lung Cancer (Million US$), 2018 - 2024
  • Figure 5 13: United States - Proton Therapy Market by Retroperitoneal Sarcoma Cancer (Million US$), 2009 - 2017
  • Figure 5 14: United States - Forecast for Proton Therapy Market by Retroperitoneal Sarcoma Cancer (Million US$), 2018 - 2024
  • Figure 5 15: United States - Proton Therapy Market by Pediatric Cancer (Million US$), 2009 - 2017
  • Figure 5 16: United States - Forecast for Proton Therapy Market by Pediatric Cancer (Million US$), 2018 - 2024
  • Figure 5 17: United States - Proton Therapy Market by Gastrointestinal Tract Cancer (Million US$), 2009 - 2017
  • Figure 5 18: United States - Forecast for Proton Therapy Market by Gastrointestinal Tract Cancer (Million US$), 2018 - 2024
  • Figure 5 19: United States - Proton Therapy Market by Urinary Tract Cancer (Million US$), 2009 - 2017
  • Figure 5 20: United States - Forecast for Proton Therapy Market by Urinary Tract Cancer (Million US$), 2018 - 2024
  • Figure 5 21: United States - Proton Therapy Market by Female Pelvic Organs Cancer (Million US$), 2009 - 2017
  • Figure 5 22: United States - Forecast for Proton Therapy Market by Female Pelvic Organs Cancer (Million US$), 2018 - 2024
  • Figure 5 23: United States - Proton Therapy Market by Prostate Cancer (Million US$), 2009 - 2017
  • Figure 5 24: United States - Forecast for Proton Therapy Market by Prostate Cancer (Million US$), 2018 - 2024
  • Figure 5 25: United States - Proton Therapy Market by Breast Cancer (Million US$), 2009 - 2017
  • Figure 5 26: United States - Forecast for Proton Therapy Market by Breast Cancer (Million US$), 2018 - 2024
  • Figure 5 27: United States - Proton Therapy Market by Other Cancer (Million US$), 2009 - 2017
  • Figure 5 28: United States - Forecast for Proton Therapy Market by Other Cancer (Million US$), 2018 - 2024
  • Figure 10 1: Global - IBA Proton Therapy Sales (Million US$), 2010 - 2017
  • Figure 10 2: Global - Forecast for IBA Proton Therapy Sales (Million US$), 2018 - 2024
  • Figure 10 3: Global - Varian Medical Systems Oncology Systems Sales (Million US$), 2010 - 2017
  • Figure 10 4: Global - Forecast for Varian Medical Systems Oncology Systems Sales (Million US$), 2018 - 2024
  • Figure 10 5: Global - Elekta Radiation Technology Sales (Million US$), 2010 - 2017
  • Figure 10 6: Global - Forecast for Elekta Radiation Technology Sales (Million US$), 2018 - 2024
  • Figure 11 1: United States - Number of Patient Diagnosed With Cancer (Thousand), 2009 - 2017
  • Figure 11 2: United States - Forecast for Number of Patient Diagnosed With Cancer (Thousand), 2018 - 2024

List of Tables:

  • Table 6 1: United States - Proton Therapy Facilities in Operation
  • Table 6 2: United States - Proton Therapy Centers in Under-Construction
  • Table 6 3: United States - Proton Therapy Centers in Planning Phase
  • Table 7 1: United States - Loma Linda (LLUMC) Proton Therapy Center with Patients Treated (Number), 2008 - 2016
  • Table 7 2: United States - UCSF - CNL Proton Therapy Center with Patients Treated (Number), 2008 - 2015
  • Table 7 3: United States - Boston (NPTC) Proton Therapy Center with Patients Treated (Number), 2008 - 2016
  • Table 7 4: United States - Bloomington (MPRI, 2) Proton Therapy Center with Patients Treated (Number), 2008 - 2014
  • Table 7 5: United States - Houston (MD Anderson) Proton Therapy Center with Patients Treated (Number), 2008 - 2016
  • Table 7 6: United States - UFPTI Jacksonville Proton Therapy Center with Patients Treated (Number), 2008 - 2016
  • Table 7 7: United States - Oklahoma City (ProCure PTC) Proton Therapy Center with Patients Treated (Number), 2009 - 2017
  • Table 7 8: United States - CDH Warrenville Proton Therapy Center with Patients Treated (Number), 2010 - 2016
  • Table 7 9: United States - Philadelphia (Upenn) Proton Therapy Center with Patients Treated (Number), 2011 - 2016
  • Table 7 10: United States - Hampton (HUPTI) Proton Therapy Center with Patients Treated (Number), 2012 - 2016
  • Table 7 11: United States - New Jersey (ProCure PTC) Proton Therapy Center with Patients Treated (Number), 2012 - 2016
  • Table 7 12: United States - Seattle (SCCA ProCure PTC) Proton Therapy Center with Patients Treated (Number), 2013 - 2016
  • Table 7 13: United States - St. Louis (S. Lee King PTC) Proton Therapy Center with Patients Treated (Number), 2013 - 2016
  • Table 7 14: United States - Provision Center for Proton Therapy, Knoxville, TN with Patients Treated (Number), 2014 - 2016
  • Table 7 15: United States - San Diego (Scripps PTC) with Patients Treated (Number), 2014 - 2017
  • Table 7 16: United States - Shreveport (Willis Knighton) Proton Therapy Center with Patients Treated (Number), 2014 - 2017
  • Table 7 17: United States - Jacksonville (Ackerman CC) Proton Therapy Center with Patients Treated (Number), 2015 - 2016
  • Table 7 18: United States - Rochester (Mayo PBTC) Proton Therapy Center with Patients Treated (Number), 2015 - 2016
  • Table 7 19: United States - Brunswick (Laurie PC) Proton Therapy Center with Patients Treated (Number), 2015
  • Table 7 20: United States - Irving (Texas Center for PT) Proton Therapy Center with Patients Treated (Number), 2015 - 2017
  • Table 7 21: United States - Memphis (St. Jude PTC) Proton Therapy Center with Patients Treated (Number), 2015 - 2017
  • Table 7 22: United States - Phoenix (Mayo PBTC) Proton Therapy Center with Patients Treated (Number), 2016
  • Table 7 23: United States - Baltimore (Maryland PTC) Proton Therapy Center with Patients Treated (Number), 2016
  • Table 7 24: United States - Cincinnati (Children's PTC) Proton Therapy Center with Patients Treated (Number), 2016
  • Table 7 25: United States - Orlando (Orlando Health PTC) Proton Therapy Center with Patients Treated (Number), 2016
  • Table 7 26: United States - Cleveland (UH Sideman PTC) Proton Therapy Center with Patients Treated (Number), 2016
Back to Top